PPT-Improving access to medicines through local production:

Author : aaron | Published Date : 2018-10-21

Some New Development I P C Meeting Copenhagen through VC Zafar Mirza 18 June 2015 Brussels WHOEC Project Improving access to medical products in developing countries

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Improving access to medicines through lo..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Improving access to medicines through local production:: Transcript

Some New Development I P C Meeting Copenhagen through VC Zafar Mirza 18 June 2015 Brussels WHOEC Project Improving access to medical products in developing countries through building capacity for local production and related technology transfer. Zambia Civil Society Consultation Meeting. 1. st. October 2013 . Daniel S. . Libati. , LLB (UNZA) . CSO Consultant. Basis of CSO work?. When one speaks of civil society and its work with regards to engaging government, the first question that has to be settled before such engagement takes place is with regards to the ‘BASIS’ of such engagement.. Global context of drug regulation. Dr Lembit Rägo. Coordinator. Quality Assurance and Safety: Medicines. Essential Medicines and Health Products. World Health Organization. E-mail: . ragol@who.int. –. lessons from HIV. EPIP, 5 September 2017, Bordeaux. . Ellen ‘t Hoen, LLM. University Medical Centre Groningen, Global Health Unit. @. ellenthoen. www.medicineslawandpolicy.org. Brief history. Stops AIDS National Gathering . 1st November 2014. Aliénor Devali. ère. Health. Action International (HAI) Europe. This document arises from HAI Europe’s Operating Grant 2014, which has received funding from the . Gilles Forte. Policy. , Access and Use Team. Department for Essential . Medicines and Health Products. World Health Assembly Resolution 67.22 . Access . to essential medicines. Recognize . the importance of effective national medicines policies, and their . Gilles . Forte. Coordinator, Policy, Access and Use Team. Essential . Medicines . and . Health Products. . WHO . mandate . within the . International . Drug Control Conventions. 1961 . Single Convention on Narcotic Drugs (Article 3). PARTNERSHIP. Medicines for Europe Vision 2020 . Our 5 pillars. 2. PATIENTS. Medicines For Europe . VISION. QUALITY. VALUE. SUSTAINABILITY. Pressure on EU budgets . Reduction. of . healthcare. . spending. Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. EMP - Technical Briefing Seminar. . 1 November, 2013. WHO HQ, Geneva. Zafar . Mirza. Public . Health, Innovation and Intellectual . Property Unit. Essential Medicines & Health Products Department . By Laura Christian, Linda Collins, . Maythiwan. . Kiatgrajai. , . Agathe. Merle, . Nayantara. . Mukherji. , Alissa . Quade. Outline. Methodology. Overview. Definitions. Harmful Effects. Extent of the Problem. Herbal preparations . could . be regarded as the original biologic approach to medicine.. Herbal medicines can be applied to the treatment of a variety of ailments, . including both . acute and chronic . Some New Development. I P C Meeting, Copenhagen (through VC). Zafar Mirza. 18 June 2015, Brussels. . WHO/EC Project:. . “. Improving access to medical products in developing countries through building capacity for local production and related technology transfer”. Dr Cécile . Macé. . WHO EMP , Mr Arne-Petter . Sanne. WHO MND, . Mr . Ajuebor. Onyema WHO MND. NCD Programme Managers Seminar. 4 June 2014. Access to NCD essential medicines . on the global agenda. Once . the protection of the product . expires for . example, patents or regulatory protection such as data . exclusivity, . the company no longer has exclusive rights to sell the medicine. . Other .

Download Document

Here is the link to download the presentation.
"Improving access to medicines through local production:"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.